phentermine and caffeine

phentermine has been researched along with caffeine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (10.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	4 (40.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bouttier, D; Julou, L; Sigwald, J; Thomas, J	1
Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS	1
Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW	1
Anderson, T; Bray, GA; Hurry, M; Lieberman, HR; Magill, RA; Rood, J; Ryan, DH; Smith, SR; Volaufova, J; Waters, WF	1
Bray, GA; Lieberman, HR; Magill, RA; McNevin, N; Ryan, DH; Smith, SR; Volaufova, J; Waters, WF	1

Reviews

2 review(s) available for phentermine and caffeine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Challenges in obesity management. Southern medical journal, 1998, Volume: 91, Issue:8 Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline	1998

Trials

2 trial(s) available for phentermine and caffeine

Article	Year
A comparison of tyrosine against placebo, phentermine, caffeine, and D-amphetamine during sleep deprivation. Nutritional neuroscience, 2003, Volume: 6, Issue:4 Topics: Adolescent; Adult; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Habituation, Psychophysiologic; Humans; Male; Phentermine; Placebos; Sleep; Sleep Deprivation; Sleep, REM; Time Factors; Tyrosine	2003
Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation. Nutritional neuroscience, 2003, Volume: 6, Issue:4 Topics: Adolescent; Adult; Caffeine; Central Nervous System Stimulants; Cognition; Dextroamphetamine; Double-Blind Method; Humans; Male; Motor Activity; Phentermine; Placebos; Sleep Deprivation; Tyrosine	2003

Article

Year

A comparison of tyrosine against placebo, phentermine, caffeine, and D-amphetamine during sleep deprivation.

Nutritional neuroscience, 2003, Volume: 6, Issue:4

Topics: Adolescent; Adult; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Double-Blind Method; Habituation, Psychophysiologic; Humans; Male; Phentermine; Placebos; Sleep; Sleep Deprivation; Sleep, REM; Time Factors; Tyrosine

2003

Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation.

Nutritional neuroscience, 2003, Volume: 6, Issue:4

Topics: Adolescent; Adult; Caffeine; Central Nervous System Stimulants; Cognition; Dextroamphetamine; Double-Blind Method; Humans; Male; Motor Activity; Phentermine; Placebos; Sleep Deprivation; Tyrosine

2003

Other Studies

6 other study(ies) available for phentermine and caffeine

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
[Therapy of hypersomnia]. Revue neurologique, 1967, Volume: 116, Issue:6 Topics: Amphetamine; Animals; Antidepressive Agents; Appetite Depressants; Bemegride; Caffeine; Cats; Central Nervous System Stimulants; Chlorphentermine; Desipramine; Electroencephalography; Ephedrine; Glycolates; Humans; Hydroxybutyrates; Imipramine; Mice; Narcolepsy; Pemoline; Phentermine; Piperidines; Rabbits; Rats; Sleep Wake Disorders; Strychnine; Sympathomimetics	1967
Pharmaceutical cost savings of treating obesity with weight loss medications. Obesity research, 1999, Volume: 7, Issue:6 Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug Costs; Ephedrine; Female; Fenfluramine; Humans; Hyperlipidemias; Hypertension; Male; Mazindol; Middle Aged; Obesity; Phentermine; Risk Factors; Weight Loss	1999